-
Cost Calculator of Immunotherapies in 1L Endometrial Cancer Treatment for the Deficient Mismatch Repair, Proficient Mismatch Repair, and Intention-to-Treat Populations From the Brazilian Private Healthcare System
Sep 9, 2025, 16:22 PM -
Economic Burden Of Primary Biliary Cholangitis (PBC) in Spain
Sep 9, 2025, 16:22 PM -
Evaluating the Potential Health and Economic Impact of V116 vs. PCV20 on Invasive Pneumococcal Disease Among Adults in the United Kingdom
Sep 9, 2025, 16:22 PM -
Artificial Intelligence in Evidence Synthesis: A Systematic Review and Meta-Analysis of Emerging Biologics for Improving Skeletal Health in Osteogenesis Imperfecta
Sep 9, 2025, 16:22 PM -
How Are Clinical Trials for Breast Cancer Treatments Currently Being Designed? A Clinical Trial Database Analysis
Sep 9, 2025, 16:22 PM -
Healthcare Costs in Older Adults: XGBoost, NNA, and Logit
Sep 9, 2025, 16:22 PM -
Optimizing PICO Scoping in EU HTA: Lessons From a HTA Coordination Group PICO Exercise in Advanced NSCLC to Inform Future Best Practice
Sep 9, 2025, 16:22 PM -
Beyond the QALY: An Analysis of Uncaptured Benefits in NICE Oncology Technology Appraisals 2023-2025
Sep 9, 2025, 16:22 PM -
Understanding Reimbursement and Access Policies for Immunoglobulins and Other Plasma-Derived Medicinal Products Across Europe
Sep 9, 2025, 16:22 PM -
Impact Of Dupilumab Treatment on Work-Related Medical Leave In Patients With Atopic Dermatitis in a Colombian Health Insurance Provider: An Observational Real-World Practice Study
Sep 9, 2025, 16:22 PM -
Patient Preferences in Gene Therapy Development for Arrhythmogenic Cardiomyopathy: The UR-HEART Qualitative Study
Sep 9, 2025, 16:22 PM -
Balancing Cost-Effectiveness With Societal Values: A Representative Survey of Norwegian Attitudes Toward Healthcare Resource Allocation
Sep 9, 2025, 16:22 PM -
Care of Patients With Phenylketonuria (PKU) in Germany a Claims Data Analysis From 2013 to 2023
Sep 9, 2025, 16:22 PM -
Preventing Bleeds in Pediatric Patients With Hemophilia A: Which Factor Replacement Therapy Offers the Best Protection and at What Cost?
Sep 9, 2025, 16:22 PM -
From Code to Quality: Identifying Quality Assurance Steps for AI Integration in Qualitative Healthcare Research: A Comparative Study of ChatGPT, Atlas.ti, and Traditional Coding
Sep 9, 2025, 16:22 PM -
Launch Price Dynamics of Targeted Therapies in NSCLC: Dissecting the Cost and Value Across Biomarker Segments
Sep 9, 2025, 16:22 PM -
Real-World Findings From the Provent Study of Dupilumab Therapy for Severe Asthma: 2-Year Analysis
Sep 9, 2025, 16:22 PM -
Cost per Responder Analysis of Certolizumab Pegol vs. Adalimumab in Patients With Moderate to Severe Active Rheumatoid Arthritis and High Rheumatoid Factor Levels: A Payer Perspective From France, Germany, Italy, and United Kingdom
Sep 9, 2025, 16:22 PM -
A Systematic Literature Review to Identify Risk Factors and Symptoms of Long COVID-19 in Adult Indian Patients
Sep 9, 2025, 16:22 PM -
Shifts in the French HTA Transparency Committee’s Use of Indirect Comparisons: Insights From a Systematic Review of the French Transparency Committee (TC) Opinions
Sep 9, 2025, 16:22 PM
